Abstract
Objective To develop an accurate method for converting dose-area product (DAP) to patient dose for dental cone-beam computed tomography (CBCT) using deep learning.
Methods 24,384 CBCT exposures of an adult phantom were simulated with PCXMC 2.0, using permutations of tube voltage, filtration, source-isocenter distance, beam width/height and isocenter position. Equivalent organ doses as well as DAP values were recorded. Next, using the aforementioned scan parameters as inputs, neural networks (NN) were trained using Keras for estimating the equivalent dose per DAP for each organ. Two methods were explored for positional input features: (1) ‘Coordinate’ mode, which uses the (continuous) XYZ-coordinates of the isocenter, and (2) ‘AP/JAW’ mode, which uses the (categorical) anteroposterior and craniocaudal position. Each network was trained, validated and tested using a 3/1/1 data split. Effective dose (ED) was calculated from the combination of NN outputs using ICRP 103 tissue weighting factors. The performance of the resulting NN models for estimating ED/DAP was compared with that of a multiple linear regression (MLR) model as well as direct conversion coefficients (CC).
Results The mean absolute error (MAE) for organ dose / DAP on the test data ranged from 0.18% (bone surface) to 2.90% (oesophagus) in ‘Coordinate’ mode and from 2.74% (red bone-marrow) to 14.13% (brain) in ‘AP/JAW’ mode. The MAE for ED was 0.23% and 4.30%, respectively, for the two modes, vs. 5.70% for the MLR model and 20.19%-32.67% for the CCs.
Conclusion NNs allow for an accurate estimation of patient dose based on DAP in dental CBCT.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
R. Pauwels was supported by the European Union Horizon 2020 Research and Innovation Program under the Marie Skłodowska-Curie Grant agreement number 754513 and by Aarhus University Research Foundation (AIAS-COFUND).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
